Related Experiment Video
Updated: Sep 13, 2025
05:26
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
Published on: September 16, 2022
4.1K
Standardized Workflow and Analytical Validation of Cell-Free DNA Extraction for Liquid Biopsy Using a Magnetic
Shivaprasad H Sathyanarayana1, Sarah B Spracklin1, Sophie J Deharvengt1
1The Laboratory for Clinical Genomics and Advanced Technology, Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Dartmouth Health, Lebanon, NH 03756, USA.
Cells
|July 25, 2025
Summary
This study validates a magnetic bead-based system for extracting circulating cell-free DNA (cfDNA), crucial for non-invasive cancer detection. The efficient and reproducible method ensures high-quality cfDNA suitable for downstream genomic analysis.
Area of Science:
- Molecular Biology
- Biochemistry
- Genomics
Background:
- Circulating cell-free DNA (cfDNA) is a vital biomarker for non-invasive cancer detection.
- Pre-analytical variables significantly affect cfDNA yield, integrity, and quality.
- Standardized cfDNA extraction is critical for reliable liquid biopsy applications.
Purpose of the Study:
- To analytically validate a magnetic bead-based, high-throughput cfDNA extraction system.
- To assess the system's efficiency, reproducibility, and compatibility with downstream molecular assays.
- To evaluate the impact of pre-analytical variables on cfDNA quality and stability.
Main Methods:
- Validation using synthetic cfDNA, ctDNA reference materials, and clinical specimens.
- Analysis of cfDNA concentration, integrity (fragment size), and purity (gDNA contamination).
- Next-generation sequencing (NGS) for variant detection accuracy using reference materials.
Main Results:
- High cfDNA recovery rates and consistent fragment size distribution (predominantly 150-200 bp).
- Minimal genomic DNA contamination observed in extracted cfDNA.
- Strong concordance between detected and expected variants in reference materials.
- Robust performance across various sample types and storage conditions (up to 48h at 4°C/RT).
Conclusions:
- The magnetic bead-based cfDNA extraction system demonstrates high efficiency, reproducibility, and reliability.
- The validated workflow is suitable for diverse downstream molecular applications, including NGS-based variant detection.
- Standardized pre-analytical workflows are essential for successful liquid biopsy implementation in oncology.
